0001145549-23-015651.txt : 20230309 0001145549-23-015651.hdr.sgml : 20230309 20230309110640 ACCESSION NUMBER: 0001145549-23-015651 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 EFFECTIVENESS DATE: 20230309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASYMmetric ETFs Trust CENTRAL INDEX KEY: 0001833032 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23622 FILM NUMBER: 23718652 BUSINESS ADDRESS: STREET 1: 158 EAST 126TH STREET, SUITE 304 CITY: NEW YORK STATE: NY ZIP: 10035 BUSINESS PHONE: 917-674-1005 MAIL ADDRESS: STREET 1: 158 EAST 126TH STREET, SUITE 304 CITY: NEW YORK STATE: NY ZIP: 10035 0001833032 S000070934 ASYMsharesTM ASYMmetric S&P 500 ETF C000225261 ASYMsharesTM ASYMmetric S&P 500 ETF ASPY 0001833032 S000079449 ASYMmetric Smart Alpha S&P 500 ETF C000240486 ASYMmetric Smart Alpha S&P 500 ETF ZSPY 0001833032 S000079450 ASYMmetric Smart Income ETF C000240487 ASYMmetric Smart Income ETF MORE N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001833032 XXXXXXXX true false false N-1A true ASYMmetric ETFs Trust 811-23622 0001833032 549300LLJEKEDJNOLR32 158 East 126th Street Suite 304 New York 10035 US-NY US 2127551970 U.S. Bancorp Fund Services LLC 615 E. Michigan St. Milwaukee 53202 4142873700 Transfer agency fund accounting and fund administration data U.S. Bank National Association 1555 N. Rivercenter Drive Suite 302 Milwaukee 53212 18336121912 Custody data ASYMmetric ETFs LLC 158 East 126th Street Suite 304 New York 10035 12127551970 Adviser data N N N N-1A 1 Y Darren Schuringa N/A Y William Thomas 001410255 N Suzanne Siracuse N/A N Winston I. Lowe N/A N Vivienne Hsu 002951451 N Douglas Tyre N/A 480 E. Swedesford Rd Suite 220 Wayne 19087 XXXXXX N N N N N N N Foreside Fund Services, LLC 8-51293 000046106 N/A N N Cohen & Company, Ltd. 00925 N/A N N N N N N N ASYMshares ASYMmetric S&P 500 ETF S000070934 549300LLJEKEDJNOLR32 Y 1 0 0 Exchange-Traded Fund N N Y N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 6c-11 (17 CFR 270.6c-11) Rule 18f-4 (17 CFR 270.18f-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Rule 18f-4(c)(2) (17 CFR 270.18f-4(c)(2)) N N N N ASYMmetric ETFs, LLC 801-120226 000312297 N/A N Toroso Investments, LLC 801-76857 000164201 N/A N N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Interncontinental Exchange Inc. 5493000F4ZO33MV32P92 N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N N US Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N/A N N N MISCHLER FINANCIAL GROUP, INC. 8-48067 000037818 2549004IPXPSM9EJFC92 6234.000000000000 Mirae Asset Securities Inc. 8-45034 000030679 25490087B4GFZLJZE912 3358.000000000000 Merrill Lynch Inc 8-33359 000016139 549300PMHS66E71I2D34 3182.000000000000 Goldman Sachs & Co 8-129 000000361 FOR8UP27PHTHYVLBNG30 866.000000000000 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 201.000000000000 WALLACHBETH CAPITAL LLC 8-67936 000147853 549300R371KUKXEXC133 106.000000000000 Telsey Advisory Group LLC 8-67988 000148234 54930080BFVVEZCZGF48 24.000000000000 13971.000000000000 0.000000000000 N 29053758.000000000000 N N N ASYMshares ASYMmetric S&P 500 ETF S000070934 Y 30000.000000000000 31.221400000000 31.216561330000 68.778500000000 31.216548880000 22.895100000000 36.710452750000 43.771500000000 36.710452750000 N/A 300.000000000000 N/A N/A 300.000000000000 N/A N/A 300.000000000000 N/A N/A 300.000000000000 N/A true INTERNAL CONTROL RPT 2 internal-control.htm ASPYINTERNALCONTROL

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Trustees of
ASYMmetric ETFs™ Trust

In planning and performing our audit of the financial statements of ASYMshares™ ASYMmetric S&P 500® ETF (the “Fund”), a series of ASYMmetric ETFs™ Trust, as of and for the year ended December 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2022.

This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.


/s/ COHEN & COMPANY, LTD.
Cleveland, Ohio
March 1, 2023